Corporate insider profile
Dennis Podlesak Insider Trades
Dennis Podlesak has reported no open-market purchases on SEC Form 4 and is a net seller of $113,716 across 1 company. The most recent open-market transaction was reported on Oct 29, 2026. Source: SEC Form 4 filings.
Latest reported as Director of Syndax Pharmaceuticals Inc (SNDX).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$113,716.00
- Latest transaction
- Oct 29, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Dennis Podlesak insider trading FAQ
- Is Dennis Podlesak buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Dennis Podlesak is a net seller of $113,716, with no open-market purchases reported. The latest transaction was reported on Oct 29, 2026.
- Which companies does Dennis Podlesak report insider trades for?
- Dennis Podlesak has reported open-market trades in Syndax Pharmaceuticals Inc (SNDX). The latest SEC-reported relationship is Director of Syndax Pharmaceuticals Inc (SNDX).
- Where does Dennis Podlesak's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1314595, and refreshes this page daily.
